Hantavirus as a persistent zoonotic risk: epidemiology and current pharmacological management

Salvatore Di Maria, Alessio Provenzani · 2026

Read Hantavirus as a persistent zoonotic risk: epidemiology and current pharmacological management by Salvatore Di Maria, Alessio Provenzani (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13631434.txt.

Description

Di Maria and Provenzani review hantavirus, a virus passed from animals that will not go away, and the drug care for it, in a review from twenty twenty-six. The virus rides rodents, makes few people ill, and hits those few hard. An Andes virus outbreak in 2026, tied to a cruise ship, drew focus from the world. How it spreads, who is at risk, and how ready lands are all stay open.

Pets are not home hosts for the virus, though pet rats have sparked Seoul virus cases. Care that props the body up is the norm, and ribavirin helps just in the early renal form. Lab-made monoclonal antibodies and host-aimed drugs show hope in labs but lack proof in clinics. Folks with a new organ can show odd, at times deadly, signs that mimic organ rejection. Joined-up watch and One Health readiness are the top tasks.

Catalog record

CREATORSalvatore Di Maria, Alessio Provenzani
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13631434

Browse the full library · About the Tower of Babel